company background image
ILM1 logo

Medios XTRA:ILM1 Stock Report

Last Price

€13.84

Market Cap

€353.1m

7D

-7.0%

1Y

-20.5%

Updated

20 Nov, 2024

Data

Company Financials +

Medios AG

XTRA:ILM1 Stock Report

Market Cap: €353.1m

ILM1 Stock Overview

Supplies specialty pharmaceutical drugs primarily in Germany. More details

ILM1 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance2/6
Financial Health5/6
Dividends0/6

Rewards

Trading at 83.4% below our estimate of its fair value

Earnings are forecast to grow 45.02% per year

Risk Analysis

Shareholders have been diluted in the past year

Profit margins (0.7%) are lower than last year (1.1%)


Medios AG Competitors

HAEMATO

HMSE:HAEK

€74.2m

M1 Kliniken

XTRA:M12

€319.1m

RHÖN-KLINIKUM

XTRA:RHK

€843.4m

Stratec

XTRA:SBS

€339.8m

Price History & Performance

Summary of all time highs, changes and price drops for Medios
Historical stock prices
Current Share Price€13.84
52 Week High€18.50
52 Week Low€13.74
Beta1.06
11 Month Change-8.59%
3 Month Change-17.22%
1 Year Change-20.46%
33 Year Change-62.13%
5 Year Change-44.64%
Change since IPO77.46%

Recent News & Updates

Recent updates

Medios (ETR:ILM1) Is Posting Promising Earnings But The Good News Doesn’t Stop There

May 21
Medios (ETR:ILM1) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Here's Why Medios (ETR:ILM1) Can Manage Its Debt Responsibly

Aug 19
Here's Why Medios (ETR:ILM1) Can Manage Its Debt Responsibly

Is Medios AG (ETR:ILM1) Trading At A 39% Discount?

Mar 02
Is Medios AG (ETR:ILM1) Trading At A 39% Discount?

Is Medios (ETR:ILM1) Using Too Much Debt?

Nov 27
Is Medios (ETR:ILM1) Using Too Much Debt?

Is It Too Late To Consider Buying Medios AG (ETR:ILM1)?

Oct 21
Is It Too Late To Consider Buying Medios AG (ETR:ILM1)?

Here's Why Medios (ETR:ILM1) Can Manage Its Debt Responsibly

Aug 12
Here's Why Medios (ETR:ILM1) Can Manage Its Debt Responsibly

Is Now The Time To Look At Buying Medios AG (ETR:ILM1)?

Jul 07
Is Now The Time To Look At Buying Medios AG (ETR:ILM1)?

Is Medios (ETR:ILM1) Using Too Much Debt?

Apr 28
Is Medios (ETR:ILM1) Using Too Much Debt?

Here's Why I Think Medios (ETR:ILM1) Is An Interesting Stock

Mar 07
Here's Why I Think Medios (ETR:ILM1) Is An Interesting Stock

What Does Medios AG's (ETR:ILM1) Share Price Indicate?

Feb 08
What Does Medios AG's (ETR:ILM1) Share Price Indicate?

Medios (ETR:ILM1) Has A Pretty Healthy Balance Sheet

Nov 29
Medios (ETR:ILM1) Has A Pretty Healthy Balance Sheet

Is There Now An Opportunity In Medios AG (ETR:ILM1)?

Oct 02
Is There Now An Opportunity In Medios AG (ETR:ILM1)?

Medios AG's (ETR:ILM1) Intrinsic Value Is Potentially 35% Above Its Share Price

Jun 18
Medios AG's (ETR:ILM1) Intrinsic Value Is Potentially 35% Above Its Share Price

What Is Medios AG's (ETR:ILM1) Share Price Doing?

May 25
What Is Medios AG's (ETR:ILM1) Share Price Doing?

Are Medios' (ETR:ILM1) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Feb 17
Are Medios' (ETR:ILM1) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Bullish: Analysts Just Made A Significant Upgrade To Their Medios AG (ETR:ILM1) Forecasts

Jan 21
Bullish: Analysts Just Made A Significant Upgrade To Their Medios AG (ETR:ILM1) Forecasts

What You Need To Know About Medios AG's (ETR:ILM1) Investor Composition

Jan 19
What You Need To Know About Medios AG's (ETR:ILM1) Investor Composition

Is It Time To Consider Buying Medios AG (ETR:ILM1)?

Dec 24
Is It Time To Consider Buying Medios AG (ETR:ILM1)?

Analysts Are Betting On Medios AG (ETR:ILM1) With A Big Upgrade This Week

Dec 09
Analysts Are Betting On Medios AG (ETR:ILM1) With A Big Upgrade This Week

The Medios (ETR:ILM1) Share Price Is Up 128% And Shareholders Are Boasting About It

Dec 08
The Medios (ETR:ILM1) Share Price Is Up 128% And Shareholders Are Boasting About It

Medios AG's (ETR:ILM1) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Nov 22
Medios AG's (ETR:ILM1) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

What Can We Make Of Medios AG’s (ETR:ILM1) High Return On Capital?

Jun 22
What Can We Make Of Medios AG’s (ETR:ILM1) High Return On Capital?

Shareholder Returns

ILM1DE HealthcareDE Market
7D-7.0%-0.3%-0.4%
1Y-20.5%14.5%7.1%

Return vs Industry: ILM1 underperformed the German Healthcare industry which returned 17.2% over the past year.

Return vs Market: ILM1 underperformed the German Market which returned 7.8% over the past year.

Price Volatility

Is ILM1's price volatile compared to industry and market?
ILM1 volatility
ILM1 Average Weekly Movement4.0%
Healthcare Industry Average Movement4.1%
Market Average Movement4.8%
10% most volatile stocks in DE Market11.0%
10% least volatile stocks in DE Market2.4%

Stable Share Price: ILM1 has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: ILM1's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20161,000Matthias Gaertnerwww.medios.ag

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases.

Medios AG Fundamentals Summary

How do Medios's earnings and revenue compare to its market cap?
ILM1 fundamental statistics
Market cap€353.06m
Earnings (TTM)€12.88m
Revenue (TTM)€1.84b

27.4x

P/E Ratio

0.2x

P/S Ratio

Is ILM1 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ILM1 income statement (TTM)
Revenue€1.84b
Cost of Revenue€1.71b
Gross Profit€131.56m
Other Expenses€118.68m
Earnings€12.88m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.50
Gross Margin7.14%
Net Profit Margin0.70%
Debt/Equity Ratio0%

How did ILM1 perform over the long term?

See historical performance and comparison